GTx, Inc. (GTXI) Tops Q4 EPS by 6c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
GTx Provides Corporate Update and Reports Fourth Quarter and Year-End 2015 Financial Results
March 3, 2016 7:00 AM EST-- Patient enrollment underway in two Phase 2 clinical trials of enobosarm for the treatment of advanced breast cancer; preliminary data from first stage of both trials expected by end of 2016 --
-- Lead SARD candidates have been selected for additional preclinical studies necessary to initiate first in human clinical trials --
-- Patient enrollment underway in Phase 2 proof-of-concept clinical trial of enobosarm in women with Stress Urinary Incontinence; anticipate top-line data in 2016 --
-- Conference call today at 9:00 a.m. Eastern Time --
... More